<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00522704</url>
  </required_header>
  <id_info>
    <org_study_id>INCich-07-08-7403</org_study_id>
    <nct_id>NCT00522704</nct_id>
  </id_info>
  <brief_title>Correlation Between Access Blood Flow and Extracorporeal Blood Flow</brief_title>
  <official_title>Correlation Between Access Blood Flow and Extracorporeal Blood Flow</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Nacional de Cardiologia Ignacio Chavez</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>JOSE CARRASCO ARTEAGA HOSPITAL FROM Ecuadorian Institute of Social Security</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Instituto Nacional de Cardiologia Ignacio Chavez</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if Effective Extracorporeal Blood Flow(eEBF) has
      correlation with Access Blood Flow (Qa), when eEBF adjusts with Dynamic Arterial Line
      Pressure (DALP) in patients with Arteriovenous fistulae in hemodialysis treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Accesses that show a large (&gt;15%) decrement over time in vascular access blood flow are
      associated with a high risk of thrombosis. Serial measurements of vascular access blood flow
      predict access thrombosis. At the moment, the measurement of access flow is time consuming,
      operator dependent, so that it cannot be done with every treatment. We hypothesized that
      extracorporeal blood flow at pressure of -200 to -260 mmHg in arterial line has correlation
      with access blood flow and this can be used to estimate access blood flow.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2008</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Acces Blood Flow</measure>
    <time_frame>Acces Blood Flow</time_frame>
    <description>Acces Blood Flow: cuantity of Blood that Flow throw venous acces in ml/min</description>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Arteriovenous Fistula</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dynamic Arterial line Pressure (DALP)</intervention_name>
    <description>eEBF will be record with dynamic arterial line pressure of -60 mmHg (eEBF-60 mmHg), -100 mmHg (eEBF-100 mmHg), -160 mmHg (eEBF-160 mmHg), -200 mmHg (eEBF-200 mmHg) and -260 mmHg (eEBF-260 mmHg) during the first one half hour of the dialysis session. Access Blood flow will be performed with blood thermal monitor.</description>
    <other_name>BTM,</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Chronic Kidney Dissease K-DIGO 5d in hemodialysis.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with Chronic Kidney Disease K-DIGO 5d in hemodialysis treatment)

          -  Permanent vascular accesses with native arteriovenous fistulas (AVF)

          -  AVF that were at least 12 weeks old

        Exclusion Criteria:

          -  Inflammation and pain in AVF

          -  Negation to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Franklin B Mora, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>HOSPITAL JOSE CARRASCO ARTEAGA DEL INSTITUTO ECUATORIANO DE SEGURIDAD SOCIAL REGIONAL 3</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Luis R Mariscal, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Instituto Nacional de Cardiología Ignacio Chávez</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Guadalupe C De la Cruz, R.N.</last_name>
    <role>Study Chair</role>
    <affiliation>Instituto Nacional de Cardiología Ignacio Chávez</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Héctor G Pérez-Grovas, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Instituto Nacional de Cardiología Ignacio Chávez</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fabián H Ortiz, MsC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Clínica Kennedy, Guayaquil Ecuador</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Franklin B Mora, M.D.</last_name>
    <phone>593 72 868084</phone>
    <email>franklin.mora.bravo@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Luis R Mariscal, M.D.</last_name>
    <phone>52 55 55 7932911</phone>
    <phone_ext>1262</phone_ext>
    <email>mariscalmd@yahoo.com.mx</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Instituto Nacional De Cardiología Ignacio Chávez</name>
      <address>
        <city>Mexico City</city>
        <state>Distrito Federeal</state>
        <zip>14080</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luis R Mariscal, M.D.</last_name>
      <phone>52 55 557932911</phone>
      <phone_ext>1262</phone_ext>
      <email>mariscalmd@yahoo.com.mx</email>
    </contact>
    <investigator>
      <last_name>Franklin B Mora, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luis R Mariscal, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 28, 2007</study_first_submitted>
  <study_first_submitted_qc>August 29, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 30, 2007</study_first_posted>
  <last_update_submitted>November 4, 2014</last_update_submitted>
  <last_update_submitted_qc>November 4, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 6, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto Nacional de Cardiologia Ignacio Chavez</investigator_affiliation>
    <investigator_full_name>FRANKLIN MORA</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <keyword>Arteriovenous fistula</keyword>
  <keyword>Access blood flow</keyword>
  <keyword>Extracorporeal blood flow</keyword>
  <keyword>Dynamic arterial line pressure</keyword>
  <keyword>Hemodialysis treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fistula</mesh_term>
    <mesh_term>Arteriovenous Fistula</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

